References
- Browning TH, Trier JS. Organ culture of mucosal biopsies of human small intestine. J Clin Invest 1969; 48: 1423–32
- Eastwood GL, Trier JS. Organ culture of human rectal mucosa. Gastroenterology 1973; 64: 375–82
- Autrup H, Barrett LA, Jackson FE, et al. Explant culture of human colon. Gastroenterology 1978; 74: 1248–57
- Autrup H. Explant culture of human colon. Methods Cell Biol 1980; 21B: 385–401
- Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978; 75: 638–40
- Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 1988; 95: 1167–72
- Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease — enhanced production during active disease. Gut 1990; 31: 686–9
- Hawkey CJ, Truelove SC. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut 1981; 22: 190–3
- Nygård G, Berglindh T. Culture of normal and inflamed rabbit colonic explants: medium-term prostaglandin profile. Scand J Gastroenterol 1989; 24: 1135–44
- Bennett A, Stamford IF, Stockley HL. Estimation and characterization of prostaglandins in the human gastrointestinal tract. Br J Pharmacol 1977; 61: 579–86
- Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its, functiondisease, or treatment?. Gastroenterology 1985; 89: 1162–88
- Mann NS, Wright L, Brawn PN. Effect of 5-aminosalicylic acid on protein loss. Gastroenterology 1990; 98: A188
- Lowry OH, Rosebrough NJ, Farr LA, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
- Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793–8
- Elion GB, Kovensky A, Hitchings GH, Metz E, Rundles RW. Metabolic studies of, allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 1966; 15: 863–80
- Massey V, Komai H, Palmer G, Elion G. On the mechanism of inactivation of xanthine oxidase by allopurinol and other, pyrazolo[34-d]pyrimidines. J Biol Chem 1970; 245: 2837–44
- Adkison D, Höllwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand 1986; 548: 101–7, Suppl
- Ligumsky M, Karmeli F, Sharon P, Zor U, Cohen F, Rachmilewitz D. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology 1981; 81: 444–9
- Lauritsen K, Hansen J, Bytzer P, Bukhave K, Rask-Madsen J. Effects of sulphasalazinc and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls. Gut 1984; 25: 1271–8
- Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sul-phasalazine maintenance treatment. Gut 1988; 29: 1316–21
- Zijlstra FJ, Garrelds IM, van Dijk APM, Ouwendijk RJT, Wilson JHP. Species differences in the pattern of eicosanoids produced by colonic mucosa. Gastroenterology 1991; 100: A627